Propel Bio Management »

Upstream Bio shares owned by Propel Bio Management

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 342k 9.07

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Group
Vanguard Capital Management
Omega Fund Management
State Street Corporation
Y-Intercept
Federated Investors
Geode Capital Management
Millennium Management
Wellington Management Company
SEB Asset Management AB

View all funds holding Upstream Bio